Status:
RECRUITING
Acute Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
Lead Sponsor:
University of Sao Paulo
Conditions:
Myopathy
Neurologic Manifestations
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Systemic autoimmune myopathies are a heterogeneous group of rheumatic diseases that primarily affect the skeletal muscles. The transcranial direct current stimulation technique has been frequent, for ...
Detailed Description
Currently, there are no studies evaluating the transcranial current stimulation technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, ran...
Eligibility Criteria
Inclusion
- Classification criteria - EULAR/ACR 2017
- Classification critera - Connors et al.
- Objective muscle limb weakness
Exclusion
- Neoplasia
- Using heart pacemarker
- Using visceral metalic clips
- Infections (HIV, HTLV-1, Hepatitis, etc)
- Pregnance
- Previous historical of convulsions or epilepsies
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 4 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03749538
Start Date
October 1 2018
End Date
December 4 2024
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samuel K Shinjo
São Paulo, Brazil, 01246903